FIG. 1. Prostanoic acid.
The prostaglandins are grouped according to the chemical groups on the pentane ring into types designated by the letters E, F, A, B, C and D. E-type prostaglandins have a ketone group at C9 and a hydroxyl group at Cli. In D-type prostaglandins these groups are reversed, the ketone being at C1I and the hydroxyl at C9. F-type prostaglandins have hydroxyl groups at C9 and Cli and form isomers designated x and 3, according to the plane of the hydroxyl groups. The A, B and C-type prostaglandins have a ketone group at C9 and 10-11, 11-12 and 8-12 double bonds respectively.
The prostaglandins are also grouped into mono-, bis-or tris-unsaturated classes according to the number of carbon-carbon double bonds in the side chain. The mono-unsaturated prostaglandins have only a 13-14 double bond, the bis-unsaturated have a 5-6 double bond in addition, and the trisunsaturated have a 17-18 double bond also (Andersen, 1971) . Prostaglandins E, F, A, B, C, D have a carboxyl group at C1 and a secondary alcohol group at C15.
Prostaglandins are not stored in tissues in a preformed state but are synthetized and released in response to a given stimulus (Piper and Vane, 1971) . All types of mammalian tissue that have been examined are capable of synthetizing at least a small quantity of prostaglandins. Prostaglandins are synthetized from eicosatrienoic (dihomo-y-linolenic), eicosatetraenoic (arachidonic) or eicosapentanoic acids. These compounds are incorporated in phospholipids and are converted to prostaglandins by the action of cyclo-oxygenase (Samuelsson, 1976 ). This enzyme, previously known as prostaglandin synthetase, is present in the microsomal fraction of cells and initially brings about cyclization and inclusion of molecular oxygen in the precursor. The action of cyclo-oxygenase (and therefore synthesis of prostaglandins) is inhibited by aspirin-like drugs (Vane, 1971; Lands et al., 1974) .
In the formation of bis-unsaturated compounds, for example when phospholipids have been hydrolysed by phospholipase A, arachidonic acid is acted on by cyclo-oxygenase or by lipoxygenase (which forms HETE but not prostaglandins). The cyclooxygenase initially stimulates formation of the cyclic-endoperoxides, prostaglandins G2 and H2 (Fig. 2) . Prostaglandins G2 and H2 are then converted to either prostaglandins E2, D2, F2. or thromboxane A2 which is unstable and decays to thromboxane B2; in some tissues, e.g. lung or platelets, the main products of arachidonic acid metabolism are thromboxanes rather than prostaglandins (Hamberg, Svensson and Samuelsson, 1976) . Conversion of the endoperoxides to thromboxanes is enzymically controlled by thromboxane synthetase (Needleman et al., 1976) . As recently shown by Moncada et al. (1976) , when prostaglandins G2 or H2 act on blood vessel walls prostacyclin (prostaglandin 12) is formed enzymatically. The stable metabolite of prostacyclin is 6-oxoprostaglandin F1j,.
The possibility exists for some interconversion of prostaglandins, for example prostaglandin E2 may be reduced to prostaglandin F2, by the action of 9-oxo-reductase which is present in tissues of a number of species (Hensby, 1974) . E-type prostaglandins are converted to A-type by acid or alkaline conditions (outside the range pH 5-8) and A-type rearranges to B in alkaline solution (Andersen, 1971 ). An isomerase present in plasma of some species converts prostaglandins A first to prostaglandin C and then to B (Jones, 1972) .
Prostaglandins of the E and F series have a short group.bmj.com on July 9, 2017 -Published by http://pmj.bmj.com/ Downloaded from half-life in the circulation and lose up to 95%4 of their biological activity on one passage through the pulmonary circulation and are further degraded on passage through other vascular beds (Ferreira and Vane, 1967) . Initially the prostaglandins are taken up from the vascular space (Bito, 1975) and then metabolized by a series of enzymes to metabolites which usually have less biological activity than the prostaglandins (Crutchley and Piper, 1975) . The enzymes are present in the soluble fraction of cells and are shown in Fig. 3 . 15-OH prostaglandin dehydrogenase causes the oxidation of the secondary alcohol group at C15 which is the rate-limiting step in the breakdown of prostaglandins. A-type prostaglandins are not so rapidly metabolized by prostaglandin dehydrogenase and do not lose activity in the pulmonary circulation but in the hepatic portal circulation (Horton and Jones, 1969) . A-type prostaglandins lose activity on conversion to prostaglandin B which is biologically inactive. The pulmonary metabolites of the prostaglandins are further broken down in the liver and kidney by n-oxidation to dinor-(eighteen C atoms) and tetranor-(sixteen C atoms) derivatives and finally undergo 5-oxidation (Samuelsson et al., 1971) . The resulting metabolites are excreted in the urine and are biologically inactive.
